Combination of low-dose docetaxel and standard-dose S-1 for the treatment of advanced gastric cancer: efficacy, toxicity, and potential predictive factor

Author： Cui Yuehong   Li Qian   Yu Yiyi   Chen Yong   Feng Yi   Wang Yan   Liu Tianshu  

Publisher： Springer Publishing Company

ISSN： 0344-5704

Source： Cancer Chemotherapy and Pharmacology, Vol.71, Iss.1, 2013-01, pp. : 145-152

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

High efficacy of combination chemotherapy with S-1 and low-dose docetaxel for the treatment of highly advanced gastric cancer with peritoneal dissemination: A case report

By Zhu Lucheng   Luo Wenhua   Wei Juan   Zou Changlin  

Oncology Letters, Vol. 5, Iss. 5, 2013-05 ,pp. : 1509-1512

Spandidos Publications

Access to resources Recommend Favorite

Weekly, low-dose docetaxel combined with estramustine for Japanese castration-resistant prostate cancer: its efficacy and safety profile compared with tri-weekly standard-dose treatment

By Nakai Yasutomo   Nishimura Kazuo   Nakayama Masashi   Uemura Motohide   Takayama Hitoshi   Nonomura Norio   Tsujimura Akira  

International Journal of Clinical Oncology, Vol. 19, Iss. 1, 2014-02 ,pp. : 165-172

Springer Publishing Company

Access to resources Recommend Favorite

A randomized phase II study comparing S-1 plus weekly split-dose cisplatin with S-1 plus standard-dose cisplatin as first-line chemotherapy for advanced gastric cancer

By Moriwaki Toshikazu   Hirai Shinji   Hironaka Shuichi   Amagai Kenji   Soeda Atsuko   Sato Mikio   Nihei Takeshi   Hirose Mitsuaki   Matsuda Kenji   Ohkawara Atsushi   Yamaguchi Taketo   Ozeki Mitsuharu   Mamiya Takashi   Murashita Tetsuya   Hyodo Ichinosuke  

Gastric Cancer, Vol. 17, Iss. 2, 2014-04 ,pp. : 354-361

Springer Publishing Company

Access to resources Recommend Favorite

Clinical and pathological disappearance of peritoneal dissemination in a patient with advanced gastric cancer receiving chemotherapy with S-1 and low-dose cisplatin

By Akatsu Yukako   Saikawa Yoshiro   Kubota Tetsuro   Yoshida Masashi   Furukawa Toshiharu   Otani Yoshihide   Kumai Koichiro   Kitajima Masaki  

Gastric Cancer, Vol. 7, Iss. 2, 2004-06 ,pp. : 128-133

Springer Publishing Company

Access to resources Recommend Favorite

Dose-finding study of docetaxel, oxaliplatin, and S-1 for patients with advanced gastric cancer

By Zang Dae   Yang Dae   Kim Min-Jeong   Jang Kyung   Hwang Se   Yoo Kyo-Sang   Han Taeho   Kim Ho   Kim Hyo   Kwon Jung   Song Hun   Park Sarah   Jung Joo   Kim Hyeong   Kim Jung  

Cancer Chemotherapy and Pharmacology, Vol. 64, Iss. 5, 2009-10 ,pp. : 877-883

Springer Publishing Company

Access to resources Recommend Favorite